Global Pediatric Vaccine Market Report 2024

Pediatric Vaccine Global Market Report 2024 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, Allergy, Cancer) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Pediatric Vaccine Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Pediatric Vaccine Market Definition And Segments

Pediatric vaccines refer to medications that are typically given to children as a form of protection against serious, frequently fatal diseases. They get the children’s body ready to battle the disease more quickly and successfully by boosting its natural defenses.

The main types of pediatric vaccines are monovalent and multivalent. A monovalent vaccine is made up of only one antigen strain. The technology used includes live attenuated, inactivated, toxoid, conjugate, and other technologies to provide immunity from infectious disease, allergy, and cancer.

The pediatric vaccine market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies

3) By Application: Infectious Disease, Allergy, Cancer

The pediatric vaccine market size has grown strongly in recent years. It will grow from $49.89 billion in 2023 to $53.52 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increased prevalence of chronic diseases, immunization policies to eradicate endemic diseases, increased funding for vaccine development.

The pediatric vaccine market size is expected to see rapid growth in the next few years. It will grow to $83.49 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing cases of invasive cervical cancer, strong late-stage pipeline and new drug approvals, increasing prevalence of infectious diseases. Major trends in the forecast period include developing combination vaccines to meet market demand, consider investing R&D activities for the development of effective vaccines, focusing on developing live attenuated vaccines, utilizing new immune engineering and advance delivery systems and implementing artificial intelligence (AI) in vaccine development to simplify the process and make manufacturing easy.

Growing Prevalence Of Chronic Diseases In Children Boosts Pediatric Vaccine Market

The rising prevalence of chronic diseases such as tuberculosis, diphtheria, and pneumonia in the age group of 15 years and below will contribute to the growth of the pediatric vaccines market. The risk of severe disease outcomes and complications of infectious diseases are increasing in children and adolescents with chronic conditions. in March 2022, according to the Australian Bureau of Statistics, an Australia-based self-governing statutory body entrusted with gathering and evaluating data and providing factual recommendations, about half of the overall population (46.6%, or 11.6 million) had at least one chronic condition. The increased prevalence of chronic diseases among children rises the demand for immunization from chronic diseases, hence, driving the growth of the pediatric vaccine market.

Rising Prevalence Of Pediatric Diseases Drives Growth In The Pediatric Vaccine Market

The increasing prevalence of pediatric diseases is expected to propel the growth of the pediatric vaccine market in the coming years. Pediatric diseases are disorders that afflict children between the ages of infancy and puberty. These disorders can be moderate to severe, and they can be either chronic or acute. Pediatric vaccinations are critical to the prevention and control of a wide spectrum of pediatric disorders. They are given to newborns and children to protect them from numerous infectious illnesses. For instance, in April 2023, according to Asthma + Lung UK, a UK-based non-profit group dedicated to preserving the right to breathe, in England and Wales, hospital stays for kids with asthma increased by 149% between 2021 and 2022. During 2020 and 2021, 19,506 children were hospitalized with asthma symptoms, compared to 7,850 during the years 2020 and 2021. Therefore, the increasing prevalence of pediatric diseases is driving the pediatric vaccine market.

Major companies operating in the pediatric vaccine market report are Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., AstraZeneca, GlaxoSmithKline PLC, Sinovac Biotech Ltd., Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo, CSL Limited, BIO-MED, Sun Pharmaceutical Industries Ltd., Sinopharm, Walvax biotechnology, Fosun Pharma, BioNTech, MCM Vaccine Company, Seqirus, Roche, Johnson & Johnson, Novartis, Connaught Laboratories, Inc., Wyeth-Ayerst, Grifols, Ataulfo de Paiva Foundation, Bio-Manguinhos–Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium

Vaccine Hesitancy Among Parents Poses Challenges For Pediatric Vaccine Market

Vaccine refusal by parents for their children is a prevailing tradition in many countries. Among the reasons for withholding children from vaccination are lack of knowledge, religious and philosophical objections, exaggerated concerns regarding vaccine safety, and others. According to a nationwide survey found that over half (51%) of pediatric services in the United States have a policy to dismiss families that refuse childhood vaccines. 37% of pediatricians themselves said they often dismissed families for refusing vaccines, and 6% said they would dismiss a family for choosing to reach out to crucial early vaccines. Governments are imposing laws and organizing awareness programs to overcome parents’ and families’ resistance to the child’s vaccine, but are unable to impose any strict rules against parents’ refusal of children’s immunization, which may hinder the pediatric vaccines market growth.

Growing Demand For Novel Vaccines Drives Innovation In Pediatric Vaccine Market

The demand for novel vaccines is steadily growing to deliver improved immunization against challenging infectious diseases (e.g., tuberculosis, HIV/ AIDS) and non-communicable chronic diseases such as cancer and neurodegenerative diseases. Novel approaches to vaccine development include structural immunogenic design, gene-based vaccine platforms, and effective adjuvant recombinant antigen formulations. To meet the increasing demand for novel vaccines, there is a continuous quest for pediatric vaccine manufacturers and developers for the innovation of vaccine design and manufacturing technologies. For instance, in April 2023, Pfizer Inc., a US-based pharmaceutical manufacturing company announced the U.S. FDA approval of REVNAR 20, a 20-valent Pneumococcal Conjugate Vaccine for children and infants.

Recent FDA Approval Of Vaccine Marks A Milestone In Pediatric Immunization

Major companies operating in the pediatric vaccine market are focusing on product approvals to better meet the needs of their existing consumers. ABRYSVO is a vaccine authorized by the FDA for use in pregnant women for the prevention of lower respiratory tract disease (LRTD) and severe LRTD triggered by respiratory syncytial virus (RSV) in children till 6 months of age. For instance, in August 2023, Pfizer Inc., a US-based pharmaceutical manufacturing company announced the U.S. FDA approval of Pfizer's ABRYSVO vaccine for the Avoidance of Respiratory Syncytial Virus (RSV) in Infants by active immunization of pregnant women 32-36 weeks gestational age. The first and only maternal vaccination approved in the United States to help prevent newborns against lower respiratory tract illness (LRTD) and severe LRTD caused by RSV from birth to six months of age.

North America was the largest region in the pediatric vaccine market in 2023. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pediatric vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The pediatric vaccine market consists of sales of BCG vaccines, hepatitis B vaccines, pentavalent vaccines, and rotavirus vaccines. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The pediatric vaccine market research report is one of a series of new reports from The Business Research Company that provides pediatric vaccine market statistics, including pediatric vaccines industry global market size, regional shares, competitors with a pediatric vaccine market share, detailed pediatric vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric vaccine industry. This pediatric vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Pediatric Vaccine Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $53.52 billion
Revenue Forecast In 2033 $83.49 billion
Growth Rate CAGR of 11.8% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies
3) By Application: Infectious Disease, Allergy, Cancer
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Merck & Co. Inc.; Serum Institute of India Pvt. Ltd.; Sanofi SA; Pfizer Inc.; AstraZeneca; GlaxoSmithKline PLC; Sinovac Biotech Ltd; Zydus Cadila; Indian Immunologicals Limited; Panacea Biotec; Takeda Pharmaceutical Company; Mitsubishi Tanabe Pharma Corporation; Daiichi Sankyo; CSL Limited; BIO-MED; Sun Pharmaceutical Industries Ltd; Sinopharm; Walvax biotechnology; Fosun Pharma; BioNTech; MCM Vaccine Company; Seqirus; Roche; Johnson & Johnson; Novartis; Connaught LaboratoriesInc.; Wyeth-Ayerst; Grifols; Ataulfo de Paiva Foundation; Bio-Manguinhos–Institute of Technology on Immunobiologicals; Butantan Institute; Ezequiel Dias Foundation (FUNED); Sinergium
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Pediatric Vaccine Market Characteristics

    3. Pediatric Vaccine Market Trends And Strategies

    4. Pediatric Vaccine Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Pediatric Vaccine Market Size and Growth

    5.1. Global Pediatric Vaccine Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Pediatric Vaccine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Pediatric Vaccine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Pediatric Vaccine Market Segmentation

    6.1. Global Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Monovalent

    Multivalent

    6.2. Global Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Live Attenuated

    Inactivated

    Toxoid

    Conjugate

    Other Technologies

    6.3. Global Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Infectious Disease

    Allergy

    Cancer

    7. Pediatric Vaccine Market Regional And Country Analysis

    7.1. Global Pediatric Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Pediatric Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Pediatric Vaccine Market

    8.1. Asia-Pacific Pediatric Vaccine Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Pediatric Vaccine Market

    9.1. China Pediatric Vaccine Market Overview

    9.2. China Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Pediatric Vaccine Market

    10.1. India Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Pediatric Vaccine Market

    11.1. Japan Pediatric Vaccine Market Overview

    11.2. Japan Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Pediatric Vaccine Market

    12.1. Australia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Pediatric Vaccine Market

    13.1. Indonesia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Pediatric Vaccine Market

    14.1. South Korea Pediatric Vaccine Market Overview

    14.2. South Korea Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Pediatric Vaccine Market

    15.1. Western Europe Pediatric Vaccine Market Overview

    15.2. Western Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Pediatric Vaccine Market

    16.1. UK Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Pediatric Vaccine Market

    17.1. Germany Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Pediatric Vaccine Market

    18.1. France Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Pediatric Vaccine Market

    19.1. Italy Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Pediatric Vaccine Market

    20.1. Spain Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Pediatric Vaccine Market

    21.1. Eastern Europe Pediatric Vaccine Market Overview

    21.2. Eastern Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Pediatric Vaccine Market

    22.1. Russia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Pediatric Vaccine Market

    23.1. North America Pediatric Vaccine Market Overview

    23.2. North America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Pediatric Vaccine Market

    24.1. USA Pediatric Vaccine Market Overview

    24.2. USA Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Pediatric Vaccine Market

    25.1. Canada Pediatric Vaccine Market Overview

    25.2. Canada Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Pediatric Vaccine Market

    26.1. South America Pediatric Vaccine Market Overview

    26.2. South America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Pediatric Vaccine Market

    27.1. Brazil Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Pediatric Vaccine Market

    28.1. Middle East Pediatric Vaccine Market Overview

    28.2. Middle East Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Pediatric Vaccine Market

    29.1. Africa Pediatric Vaccine Market Overview

    29.2. Africa Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Pediatric Vaccine Market Competitive Landscape And Company Profiles

    30.1. Pediatric Vaccine Market Competitive Landscape

    30.2. Pediatric Vaccine Market Company Profiles

    30.2.1. Merck & Co. Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Serum Institute of India Pvt. Ltd.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Sanofi SA

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Pfizer Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. AstraZeneca

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Pediatric Vaccine Market Other Major And Innovative Companies

    31.1. GlaxoSmithKline PLC

    31.2. Sinovac Biotech Ltd

    31.3. Zydus Cadila

    31.4. Indian Immunologicals Limited

    31.5. Panacea Biotec

    31.6. Takeda Pharmaceutical Company

    31.7. Mitsubishi Tanabe Pharma Corporation

    31.8. Daiichi Sankyo

    31.9. CSL Limited

    31.10. BIO-MED

    31.11. Sun Pharmaceutical Industries Ltd

    31.12. Sinopharm

    31.13. Walvax biotechnology

    31.14. Fosun Pharma

    31.15. BioNTech

    32. Global Pediatric Vaccine Market Competitive Benchmarking

    33. Global Pediatric Vaccine Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Pediatric Vaccine Market

    35. Pediatric Vaccine Market Future Outlook and Potential Analysis

    35.1 Pediatric Vaccine Market In 2028 - Countries Offering Most New Opportunities

    35.2 Pediatric Vaccine Market In 2028 - Segments Offering Most New Opportunities

    35.3 Pediatric Vaccine Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Pediatric Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Pediatric Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Merck & Co. Inc. Financial Performance
  • Table 75: Serum Institute of India Pvt. Ltd. Financial Performance
  • Table 76: Sanofi SA Financial Performance
  • Table 77: Pfizer Inc. Financial Performance
  • Table 78: AstraZeneca Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Pediatric Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Pediatric Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Merck & Co. Inc. Financial Performance
  • Figure 75: Serum Institute of India Pvt. Ltd. Financial Performance
  • Figure 76: Sanofi SA Financial Performance
  • Figure 77: Pfizer Inc. Financial Performance
  • Figure 78: AstraZeneca Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the pediatric vaccine market?

Pediatric vaccines refer to medications that are typically given to children as a form of protection against serious, frequently fatal diseases. They get the children’s body ready to battle the disease more quickly and successfully by boosting its natural defences. For further insights on the pediatric vaccine market, request a sample here

How will the pediatric vaccine market drivers and restraints affect the pediatric vaccine market dynamics? What forces will shape the pediatric vaccine industry going forward?

The pediatric vaccine market growth is aided by rising prevalence of chronic diseases such as tuberculosis, diphtheria, and pneumonia in the age group of 15 years and below. However, some pediatric vaccine market restraints include vaccine refusal by parents for their children. For further insights on the pediatric vaccine market, request a sample here

What is the forecast market size or the forecast market value of the pediatric vaccine market?

The pediatric vaccine market is expected to reach $65.01 billion in 2027 at a rate of 11.1%. For further insights on the pediatric vaccine market, request a sample here

How is the pediatric vaccine market segmented?

The global pediatric vaccine market is segmented as
1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies
3) By Application: Infectious Disease, Allergy, Cancer
For further insights on the pediatric vaccine market,
request a sample here

Which region has the largest share of the pediatric vaccine market? What are the largest region's market size and growth rate?

North America was the largest region in the pediatric vaccine market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

Who are the major players in the pediatric vaccine market?

Key competitors in the pediatric vaccine market are, GlaxoSmithKline plc, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Indian Immunologicals Limited, AstraZeneca plc, CSL Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd., Panacea Biotec Ltd., Zydus Cadila, BIO-MED, Squibb, Novartis, Abbott Laboratries, Eli Lillyand Company, F. Hoffmann- La Roche Ltd., Novo Nordisk A/S, VF Corporation, Sinovac Biotech Ltd., Bristol- Myers, Sun Pharmaceutical Industries Ltd, Sellas and Takeda Pharmaceutical Company Limited, Daiichi Sankyo, Bristol- Myers, Sinovac Biotec Ltd. For further insights on the pediatric vaccine market, request a sample here.

What are the key trends in the pediatric vaccine market?

Major trends influencing the pediatric vaccine market include growing demand for novel vaccines to deliver improved immunization against challenging infectious diseases (e.g. tuberculosis, HIV/ AIDS) and non-communicable chronic diseases such as cancer and neurodegenerative diseases. Novel approaches to vaccine development include structural immunogenic design, gene-based vaccine platforms, and effective adjuvant recombinant antigen formulations. To meet the increasing demand for novel vaccines, there is a continuous quest for pediatric vaccine manufacturers and developers for the innovation of vaccine design and manufacturing technologies. For further insights on the pediatric vaccine market, request a sample here.

What are the major opportunities in the pediatric vaccine market? What are the strategies for the pediatric vaccine market?

For detailed insights on the major opportunities and strategies in the pediatric vaccine market, request a sample here.

How does the pediatric vaccine market relate to the overall economy and other similar markets?

For detailed insights on pediatric vaccine market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the pediatric vaccine industry?

For detailed insights on the mergers and acquisitions in the pediatric vaccine industry, request a sample here.

What are the key dynamics influencing the pediatric vaccine market growth? SWOT analysis of the pediatric vaccine market.

For detailed insights on the key dynamics influencing the pediatric vaccine market growth and SWOT analysis of the pediatric vaccine industry, request a sample here.